Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ
Market Cap
$1.77B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
601 of 809
Rank in Industry
331 of 445
Largest Insider Buys in Sector
HRMY Stock Price History Chart
HRMY Stock Performance
About Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
Insider Activity of Harmony Biosciences Holdings, Inc.
Over the last 12 months, insiders at Harmony Biosciences Holdings, Inc. have bought $0 and sold $389,536 worth of Harmony Biosciences Holdings, Inc. stock.
On average, over the past 5 years, insiders at Harmony Biosciences Holdings, Inc. have bought $25.07M and sold $38.05M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 7,844 shares for transaction amount of $269,049 was made by Nielsen Jack (director) on 2020‑08‑26.
List of Insider Buy and Sell Transactions, Harmony Biosciences Holdings, Inc.
| 2024-03-15 | Sale | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | 11,979 0.0211% | $32.00 | $383,328 | -6.44% | |
| 2024-03-08 | Sale | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | 194 0.0004% | $32.00 | $6,208 | -3.59% | |
| 2022-12-14 | Sale | Nielsen Jack | director | 2,834 0.0049% | $59.96 | $169,927 | -39.81% | |
| 2022-12-14 | Sale | Wicki Andreas | director | 130 0.0002% | $60.00 | $7,800 | -39.81% | |
| 2022-12-13 | Sale | Wicki Andreas | director | 6,320 0.0108% | $60.13 | $380,022 | -40.40% | |
| 2022-12-12 | Sale | Wicki Andreas | director | 22,391 0.038% | $60.36 | $1.35M | -41.12% | |
| 2022-12-09 | Sale | Nielsen Jack | director | 9,847 0.0169% | $59.89 | $589,737 | -40.08% | |
| 2022-12-08 | Sale | Nielsen Jack | director | 36,878 0.0624% | $59.90 | $2.21M | -40.84% | |
| 2022-12-07 | Sale | Nielsen Jack | director | 64,026 0.1088% | $60.35 | $3.86M | -40.94% | |
| 2022-12-05 | Sale | Wicki Andreas | director | 77,853 0.1323% | $61.23 | $4.77M | -41.65% | |
| 2022-12-02 | Sale | Serafin Andrew | CHIEF STRATEGY OFFICER | 38,000 0.0639% | $60.13 | $2.29M | -41.20% | |
| 2022-12-01 | Sale | Nielsen Jack | director | 65,652 0.1109% | $60.00 | $3.94M | -40.73% | |
| 2022-11-30 | Sale | Nielsen Jack | director | 42,667 0.0711% | $58.93 | $2.51M | -40.46% | |
| 2022-11-29 | Sale | Nielsen Jack | director | 21,333 0.0363% | $57.82 | $1.23M | -37.98% | |
| 2022-11-22 | Sale | Nielsen Jack | director | 31,902 0.0536% | $57.60 | $1.84M | -38.26% | |
| 2022-11-21 | Sale | Nielsen Jack | director | 24,898 0.0419% | $57.08 | $1.42M | -37.45% | |
| 2022-11-18 | Sale | Nielsen Jack | director | 20,800 0.0351% | $57.00 | $1.19M | -37.06% | |
| 2022-11-15 | Sale | Nielsen Jack | director | 62,933 0.1077% | $56.80 | $3.57M | -35.89% | |
| 2022-11-15 | Sale | Wicki Andreas | director | 10,961 0.0198% | $60.10 | $658,756 | -35.89% | |
| 2022-11-14 | Sale | Nielsen Jack | director | 58,667 0.0994% | $58.70 | $3.44M | -38.56% |
Insider Historical Profitability
<0.0001%
| Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | 0 0% | $31.08 | 0 | 16 | |
| Marshman Fund Trust II | 10 percent owner | 10651120 18.1847% | $31.08 | 1 | 0 | <0.0001% |
| Novo Holdings A/S | 10 percent owner | 4409803 7.5289% | $31.08 | 1 | 0 | <0.0001% |
| Nielsen Jack | director | 2571024 4.3895% | $31.08 | 5 | 30 | <0.0001% |
| Wicki Andreas | director | 2147943 3.6672% | $31.08 | 0 | 23 | |
| Jacobs John C | PRESIDENT, CEO | 0 0% | $31.08 | 0 | 10 | |
| Serafin Andrew | CHIEF STRATEGY OFFICER | 0 0% | $31.08 | 0 | 1 | |
| Dayno Jeffrey M. | CHIEF MEDICAL OFFICER | 0 0% | $31.08 | 0 | 9 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Valor Management Llc | $376.7M | 19.75 | 11.22M | 0% | +$0 | 78.55 | |
| BlackRock | $198.89M | 10.43 | 5.92M | -1.34% | -$2.71M | 0.01 | |
| Fidelity Investments | $176.48M | 9.25 | 5.26M | -0.4% | -$715,489.06 | 0.01 | |
| The Vanguard Group | $121.84M | 6.39 | 3.63M | -1.27% | -$1.56M | <0.01 | |
| Vivo Capital | $87.52M | 4.59 | 2.61M | 0% | +$0 | 7.71 | |
| Pacer Advisors Inc | $83.78M | 4.39 | 2.49M | +103.68% | +$42.65M | 0.21 | |
| State Street | $43.5M | 2.28 | 1.3M | -4.77% | -$2.18M | <0.01 | |
| venBio | $34.77M | 1.82 | 1.04M | 0% | +$0 | 12.33 | |
| Morgan Stanley | $29.73M | 1.56 | 885,345 | -18.49% | -$6.75M | <0.01 | |
| Dimensional Fund Advisors | $28.36M | 1.49 | 844,588 | +14.71% | +$3.64M | 0.01 | |
| Geode Capital Management | $25.32M | 1.33 | 753,777 | +2.01% | +$499,474.10 | <0.01 | |
| Citadel Advisors LLC | $19.53M | 1.02 | 581,620 | +638.73% | +$16.89M | 0.01 | |
| Federated Hermes | $17.65M | 0.93 | 525,541 | +0.04% | +$6,850.32 | 0.04 | |
| Standard Life | $17.07M | 0.9 | 508,249 | -4.68% | -$837,485.23 | 0.03 | |
| Massachusetts Financial Services Co Ma | $17M | 0.89 | 506,154 | -0.49% | -$83,211.24 | 0.01 | |
| American Century Investments | $14.89M | 0.78 | 443,396 | +114.8% | +$7.96M | 0.01 | |
| Nuveen | $13.55M | 0.71 | 403,369 | +0.17% | +$22,733.66 | <0.01 | |
| Renaissance Technologies | $12.76M | 0.67 | 380,100 | +47.04% | +$4.08M | 0.02 | |
| Charles Schwab | $12.54M | 0.66 | 373,516 | +17.03% | +$1.83M | <0.01 | |
| Nan Fung Group | $12.38M | 0.65 | 368,665 | 0% | +$0 | 13.46 | |
| Voloridge Investment Management, LLC | $11.63M | 0.61 | 346,226 | -15.93% | -$2.2M | 0.03 | |
| LSV Asset Management | $11.25M | 0.59 | 335,146 | +346.55% | +$8.73M | 0.02 | |
| Northern Trust | $10.86M | 0.57 | 323,514 | -2.41% | -$268,707.16 | <0.01 | |
| Macquarie Group | $10.07M | 0.53 | 299,906 | -47.89% | -$9.26M | 0.01 | |
| 683 Capital Management Llc | $9.91M | 0.52 | 295,000 | -9.23% | -$1.01M | 1.11 | |
| BNY Mellon | $9.69M | 0.51 | 288,647 | -4.89% | -$498,394.35 | <0.01 | |
| Tang Capital Management, LLC | $9.44M | 0.5 | 281,200 | +3.69% | +$335,800.00 | 0.04 | |
| D. E. Shaw & Co. | $9.38M | 0.49 | 279,435 | -0.82% | -$77,939.18 | 0.01 | |
| Jacobs Levy Equity Management | $7.97M | 0.42 | 237,327 | -0.59% | -$47,280.64 | 0.04 | |
| Goldman Sachs | $7.08M | 0.37 | 210,954 | -22.19% | -$2.02M | <0.01 | |
| Capital Management Corp Va | $7.02M | 0.37 | 208,994 | New | +$7.02M | 1.38 | |
| Millennium Management LLC | $6.81M | 0.36 | 202,729 | +803.63% | +$6.05M | 0.01 | |
| Janus Henderson | $6.21M | 0.33 | 185,083 | +1,011.68% | +$5.66M | <0.01 | |
| Schroder Investment Management Group | $5.96M | 0.31 | 177,454 | -22% | -$1.68M | 0.01 | |
| HealthInvest Partners | $5.71M | 0.3 | 170,000 | +17.24% | +$839,500.00 | 3.49 | |
| Citigroup | $5.49M | 0.29 | 163,530 | -2.09% | -$117,160.61 | 0.01 | |
| AllianceBernstein | $5.22M | 0.27 | 155,510 | -6.38% | -$355,847.27 | <0.01 | |
| AQR Capital | $5.15M | 0.27 | 153,229 | -14.76% | -$890,743.11 | 0.01 | |
| Two Sigma Advisers LP | $5.11M | 0.27 | 152,200 | -0.33% | -$16,790.00 | 0.01 | |
| Man Group Plc | $4.85M | 0.26 | 144,559 | +3.74% | +$175,119.69 | 0.01 | |
| Invesco | $4.5M | 0.24 | 133,908 | +17.28% | +$662,600.47 | <0.01 | |
| Algert Global LLC | $4.29M | 0.23 | 127,611 | -20.31% | -$1.09M | 0.17 | |
| Marshall Wace | $4.18M | 0.22 | 124,520 | New | +$4.18M | 0.01 | |
| Alphacentric Advisors Llc | $4.1M | 0.22 | 122,000 | 0% | +$0 | 2.6 | |
| UBS | $3.81M | 0.2 | 113,477 | +156.22% | +$2.32M | <0.01 | |
| RhumbLine Advisers | $3.5M | 0.18 | 104,115 | +3.55% | +$119,879.89 | <0.01 | |
| ROYCE & ASSOCIATES INC | $3.3M | 0.17 | 98,238 | -10.37% | -$381,636.70 | 0.03 | |
| Ameriprise Financial | $3.2M | 0.17 | 95,150 | -3.95% | -$131,499.28 | <0.01 | |
| Paradiem | $3.15M | 0.17 | 93,930 | -12.24% | -$439,931.52 | 0.85 | |
| Legal & General | $3.09M | 0.16 | 92,032 | -2.47% | -$78,375.71 | <0.01 |